Centre Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-101,385
Closed -$8.41M 84
2023
Q1
$8.41M Sell
101,385
-21,402
-17% -$1.77M 2.03% 15
2022
Q4
$10.5M Sell
122,787
-13,441
-10% -$1.06M 2.79% 7
2022
Q3
$8.4M Sell
136,228
-780
-0.6% -$49.2K 2.32% 14
2022
Q2
$8.47M Buy
+137,008
New +$8.48M 2.24% 17
2022
Q1
Sell
-37,649
Closed -$2.73M 66
2021
Q4
$2.73M Buy
+37,649
New +$2.59M 1.38% 30
2017
Q1
Sell
-73,185
Closed -$5.24M 57
2016
Q4
$5.24M Sell
73,185
-5,010
-6% -$372K 1.01% 47
2016
Q3
$6.19M Sell
78,195
-2,880
-4% -$234K 1.12% 42
2016
Q2
$6.76M Sell
81,075
-61,790
-43% -$5.48M 1.2% 36
2016
Q1
$13.1M Buy
142,865
+8,350
+6% +$753K 2.29% 14
2015
Q4
$13.6M Sell
134,515
-33,410
-20% -$3.48M 2.34% 9
2015
Q3
$16.5M Sell
167,925
-15,240
-8% -$1.69M 2.86% 5
2015
Q2
$21.4M Sell
183,165
-11,450
-6% -$1.25M 3.38% 3
2015
Q1
$19.1M Buy
194,615
+11,355
+6% +$1.15M 2.84% 4
2014
Q4
$17.3M Buy
183,260
+19,780
+12% +$2.05M 2.68% 4
2014
Q3
$17.4M Sell
163,480
-2,110
-1% -$207K 2.67% 4
2014
Q2
$13.7M Sell
165,590
-16,670
-9% -$1.3M 2.07% 6
2014
Q1
$12.9M Buy
182,260
+34,170
+23% +$2.68M 1.91% 10
2013
Q4
$11.1M Buy
148,090
+6,040
+4% +$421K 1.72% 14
2013
Q3
$8.93M Buy
142,050
+29,980
+27% +$1.79M 1.42% 27
2013
Q2
$5.74M Buy
+112,070
New +$5.84M 0.93% 35

Other funds holding GILD

Centre Asset Management's GILD Position: Q2 2023 in Review

Centre Asset Management sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 101,385 shares — an estimated $8.41M sold.

Centre Asset Management first reported a position in GILD in Q2 2013 and held it in 20 quarters. The position peaked at $21.4M in Q2 2015. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Centre Asset Management reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • Centre Asset Management sold 101,385 Gilead Sciences shares in Q2 2023, an estimated $8.41M.
  • Centre Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 20 quarters.
  • Centre Asset Management's Gilead Sciences position peaked at $21.4M in Q2 2015.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Centre Asset Management's 13F filing for Q2 2023, filed 6 Jul 2023.